Metipranolol patient counseling information: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Metipranolol}} {{CMG}} == <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = METIPRANOLOL SOLUTION/ DROPS [FALCON PHARMACEUTICALS, LTD....") |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
== | ==Patient Counseling Information== | ||
====Information for Patients==== | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = METIPRANOLOL SOLUTION/ DROPS [FALCON PHARMACEUTICALS, LTD.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=699ce415-0798-4244-b5ec-bcdb383b50b3#nlm34090-1 | publisher = | date = | accessdate = }}</ref> | Patients should be instructed to avoid allowing the tip of the dispensing containers to contact the eye or surrounding structures. Patients should be advised that metipranolol contains benzalkonium chloride which may be absorbed by soft contact lenses. Contact lenses should be removed prior to administration of the solution. Lenses may be reinserted 15 minutes following metipranolol administration.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = METIPRANOLOL SOLUTION/ DROPS [FALCON PHARMACEUTICALS, LTD.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=699ce415-0798-4244-b5ec-bcdb383b50b3#nlm34090-1 | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 05:28, 10 February 2014
| Metipranolol |
|---|
| METIPRANOLOL® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Metipranolol |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Patient Counseling Information
Information for Patients
Patients should be instructed to avoid allowing the tip of the dispensing containers to contact the eye or surrounding structures. Patients should be advised that metipranolol contains benzalkonium chloride which may be absorbed by soft contact lenses. Contact lenses should be removed prior to administration of the solution. Lenses may be reinserted 15 minutes following metipranolol administration.[1]
References
Adapted from the FDA Package Insert.